Patents by Inventor Amy Takvorian

Amy Takvorian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
    Patent number: 8951536
    Abstract: The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions thereof and methods of use thereof relating to the treatment of cancer and other diseases.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: February 10, 2015
    Assignee: Incyte Corporation
    Inventors: Andrew P. Combs, Amy Takvorian, Wenyu Zhu, Richard B. Sparks
  • N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
    Patent number: 8450351
    Abstract: The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions thereof and methods of use thereof relating to the treatment of cancer and other diseases.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: May 28, 2013
    Assignee: Incyte Corporation
    Inventors: Andrew P. Combs, Amy Takvorian, Wenyu Zhu, Richard B. Sparks
  • N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
    Publication number: 20070185165
    Abstract: The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions thereof and methods of use thereof relating to the treatment of cancer and other diseases.
    Type: Application
    Filed: December 19, 2006
    Publication date: August 9, 2007
    Inventors: Andrew Combs, Amy Takvorian, Wenyu Zhu, Richard Sparks
  • Inhibitors of proteins that bind phosphorylated molecules
    Patent number: 7141596
    Abstract: The present invention provides compounds that can modulate the activity of a target protein, such as a phosphatase, that selectively binds phosphorylated peptides or proteins. The present compounds can be useful in treating diseases or disorders, including, for example, diabetes and obesity, that are connected directly or indirectly to the activity of the target protein.
    Type: Grant
    Filed: October 7, 2004
    Date of Patent: November 28, 2006
    Assignee: Incyte Corporation
    Inventors: Andrew P. Combs, Eddy Wai Tsun Yue, Michael J. Bower, Wenyu Zhu, Matthew L. Crawley, Richard B. Sparks, James R. Pruitt, Amy Takvorian
  • Inhibitors of proteins that bind phosphorylated molecules
    Publication number: 20050272778
    Abstract: The present invention provides compounds that can modulate the activity of a target protein, such as a phosphatase, that selectively binds phosphorylated peptides or proteins. The present compounds can be useful in treating diseases or disorders, including, for example, diabetes and obesity, that are connected directly or indirectly to the activity of the target protein.
    Type: Application
    Filed: October 7, 2004
    Publication date: December 8, 2005
    Inventors: Andrew Combs, Eddy Yue, Michael Bower, Wenyu Zhu, Matthew Crawley, Richard Sparks, James Pruitt, Amy Takvorian